NVAX
HEALTHCARENovavax Inc
$9.36+1.26 (+15.56%)PRE
Live · NASDAQ · May 9, Close
AI Insight
What's Moving NVAX Today?
No stock-specific AI insight has been generated for NVAX yet. Check back soon — insights are generated from recent news analysis.
52-Week Range
$5.80$11.97
$9.36
Fundamentals
Market Cap$1.5B
P/E Ratio3.6
EPS$2.58
Dividend Yield—
Dividend / Share—
ROE-9.0%
Profit Margin0.4%
Debt / Equity—
Trading
Volume16.5M
Avg Volume (10D)—
Shares Outstanding164.4M
NVAX News
20 articles- Novavax to Participate in BofA Securities 2026 Health Care ConferenceYahoo Finance·May 7, 2026
- NVAX Q1 Earnings Beat, Stock Jumps 16% on Matrix-M Deal MomentumYahoo Finance·May 7, 2026
- Company News for May 7, 2026Yahoo Finance·May 7, 2026
- Novavax (NVAX) Q3 2025 Earnings TranscriptMotley Fool·May 7, 2026
- Novavax, Inc. Q1 2026 Earnings Call SummaryMoby·May 6, 2026
- Novavax Q1 Earnings Call HighlightsMarketbeat·May 6, 2026
- Novavax (NVAX) Q1 2026 Earnings TranscriptMotley Fool·May 6, 2026
- Novavax (NVAX) Q2 2025 Earnings TranscriptMotley Fool·May 6, 2026
- Novavax (NVAX) Reports Q1 Loss, Beats Revenue EstimatesYahoo Finance·May 6, 2026
- Novavax (NASDAQ:NVAX) Surprises With Strong Q1 CY2026, Stock SoarsYahoo Finance·May 6, 2026
- Novavax Reports First Quarter 2026 Financial Results and Operational HighlightsYahoo Finance·May 6, 2026
- Are These 5 Biotech Stocks Set to Beat Q1 Earnings Estimates?Yahoo Finance·May 4, 2026
- A Look At Novavax (NVAX) Valuation As It Shifts To Licensing And Awaits Combo Vaccine DataYahoo Finance·May 2, 2026
- Novavax (NVAX) Beats Stock Market Upswing: What Investors Need to KnowYahoo Finance·May 1, 2026
- Is Novavax, Inc. (NVAX) A Good Stock To Buy Now?Yahoo Finance·Apr 30, 2026
- Kura Oncology (KURA) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 ReleaseYahoo Finance·Apr 30, 2026
- Novavax to Report First Quarter 2026 Financial Results on May 6, 2026Yahoo Finance·Apr 29, 2026
- Novavax, Inc. (NVAX) is Attracting Investor Attention: Here is What You Should KnowYahoo Finance·Apr 27, 2026
- 1 Cash-Heavy Stock to Target This Week and 2 We IgnoreYahoo Finance·Apr 25, 2026
- Is Novavax (NVAX) Now Pricing In Too Much Risk After Its Recent VolatilityYahoo Finance·Apr 24, 2026
All 20 articles loaded
Price Data
Open$7.90
Previous Close$8.10
Day High$8.08
Day Low$7.86
52 Week High$11.97
52 Week Low$5.80
52-Week Range
$5.80$11.97
$9.36
Fundamentals
Market Cap$1.5B
P/E Ratio3.6
EPS$2.58
Dividend Yield—
Dividend / Share—
ROE-9.0%
Profit Margin0.4%
Debt / Equity—
Trading
Volume16.5M
Avg Volume (10D)—
Shares Outstanding164.4M
About Novavax Inc
Novavax, Inc., a biotechnology company, focuses on the discovery, development and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company is headquartered in Gaithersburg, Maryland.
HEALTHCAREBIOTECHNOLOGY
Company Details
Security TypeStock
ExchangeNASDAQ
CurrencyUSD
Round Lot—
SICBIOTECHNOLOGY
CIK—
Composite FIGI—
Share Class FIGI—